Our Publications
Show: AllPeer ReviewedNon Peer Reviewed
16 publications from 2011
McMillin DW, Delmore J, Negri J, Buon L, Jacobs HM, Laubach J, Jakubikova J, Ooi M, Hayden P, Schlossman R, Munshi NC, Lengauer C, Richardson PG, Anderson KC, Mitsiades CS., Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications., British journal of haematology, 152, (4), 2011, p420-432
McCarron SL, Kelly J, Coen N, McCabe S, Fay M, O'Dwyer M, Hayden PJ, Langabeer SE., A novel e8a2 BCR-ABL1 fusion with insertion of RALGPS1 exon 8 in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia., Leukemia & lymphoma, 52, (5), 2011, p919-921
McHugh J, Holt C, O'Keeffe D., An assessment of the utility of unselected coagulation screening in general hospital practice., Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 22, (2), 2011, p106-109
Bacon, C.L., Singleton, E., Brady, B., White, B., Nolan, B., Gilmore, R.M., Ryan, C., Keohane, C., Vince Jenkins, P. and O'Donnell, Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®), Haemophilia, 17, 2011, p407 - 411
Langabeer SE, Haslam K, Kelly J, Leahy M, Vandenberghe E, Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion., 2011
Harris LF, Castro-López V, Jenkins PV, O'Donnell JS, Killard AJ. , Comparison of a fluorogenic anti-FXa assay with a central laboratory chromogenic anti-FXa assay for measuring LMWH activity in patient plasmas., Thrombosis Research, 128, (6), 2011, p166 - 170
Harris LF, O'Brien A, Castro-López V, O'Donnell JS, Killard AJ. , Comparison of the anticoagulant response of a novel fluorogenic anti-FXa assay with two commercial anti-FXa chromogenic assays., Thrombosis Research, , 128, (6), 2011, p125 - 129
Keeney S, Cumming AM, Nash MJ, O'Donnell JS, Jenkins PV. , Clinical utility gene card for: Haemophilia A., European Journal of Human Genetics,, 19, (11), 2011, p107 - 111
Bacon CL, Singleton E, Brady B, White B, Nolan B, Gilmore R, O'Donnell JS. , Low risk of inhibitor formation in haemophilia A patients following an en masse switch in treatment to a third generation full length recombinant FVIII product. , Haemophilia, 17, (3), 2011, p407 - 411
Castro-López V, Murray B, Harris LF, O'Donnell JS, Killard AJ, Effects of four commercially available factor Xa proteins on the fluorogenic anti-factor Xa assay when monitoring unfractionated heparin., Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis, 2011
Vanessa Castro-Lopez, Leanne F. Harris, James S. O'Donnell, Anthony J. Killard, Quantification of unfractionated heparin in human plasma and whole blood by means of novel fluorogenic anti-FXa assays, Journal of Pharmaceutical and Biomedical Analysis, 56, (5), 2011, p992-997
Ni Ainle F*, O'Donnell JS* (joint first author), Johnson J, Gleeson E, Smith OP, Preston RJ. , Activated protein C N-linked glycans regulate cytoprotective signalling on endothelial cells, Journal of Biological Chemistry, 286, (2), 2011, p1323 - 1330
Cumming AM, Keeney S, Jenkins PV, Nash MJ, O'Donnell JS, Clinical utility gene card for: von Willebrand disease, European Journal of Human Genetics, Jan 5, 2011, pEpub-
Castro-Lopez V, Harris LF, O'Donnell JS and Killard AJ, Comparative study of Factor Xa fluorogenic substrates and their influence on the quantification of LMWHs, Analytical and Bioanalytical Chemistry, 399, 2011, p691 - 700
Maginn EN, Browne PV, Hayden P, Vandenberghe E, McDonagh B, Evans P, Goodyer M, Tewari P, Campiani G, Butini S, Williams DC, Zisterer DM, Lawler MP, McElligott AM., PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells., British Journal of Cancer, 104, (2), 2011, p281 - 289
Forde JC., Maginn EN., McNamara G., Martin LM., Campiani GC. , Williams DC, Zisterer D.M, McElligott AM., Lawler M, , Lynch TH, Hollywood D., Marignol L, Microtubule-Targeting-Compound PBOX-15 Radiosensitizes Cancer Cells In Vitro , Cancer Biology and Therapy, 11, (4), 2011, p6 - 13